ACE2 and COVID-19: We have recently investigated the role of the DNA methylation levels of the angiotensin-converting enzyme 2 (ACE2) in the development of post-COVID-19 symptoms in individuals who needed hospitalization due to COVID-19 during the first wave of the outbreak [22].